Government mulling roping in 3-4 more firms to ramp up DRDO COVID-19 drug production

2-DG has been developed by DRDO’s Institute of Nuclear Medicine and Allied Sciences (INMAS), in collaboration with Dr Reddy’s Laboratories, Hyderabad. Clinical trial results have shown that this molecule helps in the faster recovery of hospitalized patients and reduces supplemental oxygen dependence.